Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Coiled-coil domain-containing protein 182 (CCDC182) is a small protein (~150 amino acids) characterized by a predicted coiled-coil domain, suggesting a structural or scaffolding function within cells[1][7]. The specific biological role remains unclear, though there is limited prediction that it may play a part in female gonad development[6]. CCDC182 has no established links to known human diseases, signaling pathways, or as a druggable target. Its membership in the broader coiled-coil family implies possible involvement in intracellular organization, molecular interactions, or structural support, though direct evidence is lacking for CCDC182 itself[3]. Note: There is little experimental characterization for CCDC182 specifically, and most information is predicted or based on homology to other coiled-coil domain proteins. It is not established as a therapeutic target or disease biomarker; its molecular function is inferred but not directly demonstrated in literature or databases as of September 2025.
None known or applicable, as this is not a validated drug target
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Coiled-coil domain-containing protein 182 (CCDC182).